PharmaBlock Sciences (Nanjing), Inc. (SHE:300725)

China flag China · Delayed Price · Currency is CNY
37.33
+0.54 (1.47%)
Jul 3, 2026, 3:04 PM CST
Market Cap8.70B +24.4%
Revenue (ttm)2.03B +14.8%
Net Income196.83M -4.4%
EPS0.91 -12.1%
Shares Out 232.97M
PE Ratio41.21
Forward PEn/a
Dividend0.28 (0.75%)
Ex-Dividend DateJun 10, 2026
Volume10,732,711
Open34.20
Previous Close36.79
Day's Range34.20 - 37.80
52-Week Range30.90 - 53.54
Beta0.55
Analystsn/a
Price Targetn/a
Earnings DateAug 11, 2026

About SHE:300725

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and internationally. It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design; building blocks enabled libraries, including fragment-based drug discovery, and mega virtual library screening to support the discovery of novel hit compounds; custom synthesis (FFS); and full time equivalent (FTE). The company also provides small molecule drug substance CDMO se... [Read more]

Sector Healthcare
Founded 2006
Employees 2,593
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300725
Full Company Profile

Financial Performance

In 2025, SHE:300725's revenue was 1.97 billion, an increase of 16.93% compared to the previous year's 1.69 billion. Earnings were 183.74 million, a decrease of -16.31%.

Financial Statements